MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202521132572 A) filed by Dr. Devendra S. Shirode; Dr. Smeeta Sadar; Ms. Vaishnavi Kachare; Ms. Ashwini Gavit; Ms. Dhanashri Sonavane; and Mr. Jaydip Bhapkar, Pune, Maharashtra, on Dec. 27, 2025, for 'effects of elaeagnus conferta on behavioral and biochemical parameters in scopolamine induced alzheimer's model.'
Inventor(s) include Dr. Devendra S. Shirode; Dr. Smeeta Sadar; Ms. Vaishnavi Kachare; Ms. Ashwini Gavit; Ms. Dhanashri Sonavane; and Mr. Jaydip Bhapkar.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to the field of neurodegenerative disease management, specifically to the therapeutic potential of plant-based extracts for Alzheimer's disease (AD). It further concerns the use of Elaeagnus conferta Roxb., a traditional medicinal plant, for preventing or ameliorating the cognitive decline associated with Alzheimer's disease."
Disclaimer: Curated by HT Syndication.
